These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 1002792)
41. Synthesis of (-)-alpha-acetylmethadol metabolites and related compounds. Carroll FI; Brine GA; Chen T; Kohl DW; Welch CD J Org Chem; 1976 Oct; 41(22):3521-4. PubMed ID: 978303 [No Abstract] [Full Text] [Related]
42. Comparative study of the electroencephalographic and behavioral effects of l-alpha-acetylmethadol (LAAM), two of its metabolites and morphine and methadone in the rat. Lukas SE; Moreton JE; Khazan N J Pharmacol Exp Ther; 1980 Nov; 215(2):382-9. PubMed ID: 7441502 [No Abstract] [Full Text] [Related]
44. The effect of ethanol on the metabolism of chronically-administered l-alpha-acetylmethadol (LAAM) in the rhesus monkey. Casella GA; Deneau GA; Mule SJ Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):351-4. PubMed ID: 99782 [TBL] [Abstract][Full Text] [Related]
45. Uptake of l-alpha-acetylmethadol (LAAM) and its analgesically active metabolites, nor-LAAM and dinor-LAAM, in the isolated perfused rat lung. Roerig DL; Dahl RR; Dawson CA; Wang RI Drug Metab Dispos; 1983; 11(5):411-6. PubMed ID: 6138224 [TBL] [Abstract][Full Text] [Related]
46. LAAM and LAAM metabolites: plasma levels in patients. Summary progress report. 1975 [proceedings]. Goldstein A NIDA Res Monogr; 1976 Jul; (8):61. PubMed ID: 995180 [No Abstract] [Full Text] [Related]
47. Physiological disposition and biotransformation of l-alpha-[2-3H]acetylmethadol (LAAM) in acutely and chronically treated monkeys. Misra AL; Mulé SJ; Bloch R; Bates TR J Pharmacol Exp Ther; 1978 Aug; 206(2):475-91. PubMed ID: 98628 [No Abstract] [Full Text] [Related]
48. Binding of 1-alpha-acetylmethadol and its metabolites to blood constituents. Toro-Goyco E Biochem Pharmacol; 1980 Jul; 29(13):1897-902. PubMed ID: 6156685 [No Abstract] [Full Text] [Related]
49. The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. 1973 [proceedings]. Lehmann WX NIDA Res Monogr; 1976 Jul; (8):82-3. PubMed ID: 792705 [No Abstract] [Full Text] [Related]
50. The binding of LAAM and its metabolites to blood constituents. Toro-Goyco E; Martin BR; Harris LS NIDA Res Monogr; 1979; 27():54-60. PubMed ID: 95037 [No Abstract] [Full Text] [Related]
51. Pharmacokinetics and metabolism of (-)-alpha-[2-3H]acetylmethadol (LAAM) in the monkey: evidence for a new metabolite. Misra AL; Vardy J; Bloch R; Mulé SJ; Deneau GA J Pharm Pharmacol; 1976 Apr; 28(4):316-8. PubMed ID: 6726 [No Abstract] [Full Text] [Related]
52. Distribution of l-alpha-[2-3H]acetylmethadol and its metabolites in maternal and fetal rat tissues. Man M; Alozie SO; Woods LA; Martin BR; Harris LS Drug Metab Dispos; 1980; 8(2):55-9. PubMed ID: 6103787 [No Abstract] [Full Text] [Related]
53. Thin-layer chromatography and enzyme immunoassay of L-alpha-acetyl methadol and methadone metabolites in urine. McIntyre JA; Armandi AE; Risen LP; Ling W; Haberfelde GC Clin Chem; 1975 Jan; 21(1):109-12. PubMed ID: 1116262 [No Abstract] [Full Text] [Related]
54. Acetylmethadol metabolites influence opiate receptors and adenylate cyclase in amygdala. Walczak SA; Makman MH; Gardner EL Eur J Pharmacol; 1981 Jul; 72(4):343-9. PubMed ID: 6268422 [TBL] [Abstract][Full Text] [Related]
55. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction. Marcovici M; O'Brien CP; McLellan AT; Kacian J Am J Psychiatry; 1981 Feb; 138(2):234-6. PubMed ID: 7457647 [TBL] [Abstract][Full Text] [Related]
56. Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies. Kharasch ED; Whittington D; Hoffer C; Krudys K; Craig K; Vicini P; Sheffels P; Lalovic B Clin Pharmacokinet; 2005; 44(7):731-51. PubMed ID: 15966756 [TBL] [Abstract][Full Text] [Related]
57. Pharmacodynamics of LAAM in man: plasma levels of LAAM and its metabolites following acute and chronic administration in man (fourth and sixth quarter progress reports). 1974-5 [proceedings]. Henderson GL NIDA Res Monogr; 1976 Jul; (8):64-5. PubMed ID: 995181 [No Abstract] [Full Text] [Related]
58. Pharmacodynamic profiles of 1-alpha-acetylmethadol (LAAM) and its N-demethylated metabolites, nor-LAAM and dinor-LAAM, during self-administration in the dependent rat. Young GA; Steinfels GF; Khazan N J Pharmacol Exp Ther; 1979 Sep; 210(3):453-7. PubMed ID: 225470 [No Abstract] [Full Text] [Related]
59. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Moody DE; Alburges ME; Parker RJ; Collins JM; Strong JM Drug Metab Dispos; 1997 Dec; 25(12):1347-53. PubMed ID: 9394023 [TBL] [Abstract][Full Text] [Related]
60. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation. Oda Y; Kharasch ED J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]